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Abstract
Background: Left atrial volume (LAV) is surgically kept enlarged in heart transplant (HT) recipients. On the other
hand, LAV has been known an independent predictor of various cardiovascular diseases and is associated with
exercise capacity of HT recipients. Thus, we evaluated the hypothesis that LAV is still associated with clinical
outcomes in HT recipients whose left atria are artificially enlarged.
Methods: Clinical outcomes over 5 years after HT were retrospectively evaluated in 35 HT recipients who had a
LAV measurement with echocardiography at 1 year after HT at the University of Cincinnati Medical Center. The LAV
was derived from a stacked disc method using apical 4 and 2 chamber views.
Results: The average LAV normalized to body surface area was 38.3 ± 9.9 ml/m2 (mean ± SD) at 1 year after HT.
Two deaths and one drop-out occurred during 5-year follow up. A total of 552 cardiac symptom-related
hospitalizations occurred in the recipients. The average time to first hospitalization was 166 ± 279 days and average
number of hospitalizations of each recipient was 15 ± 16. The indexed LAV failed to correlate with the time to first
hospitalization and number of hospitalizations of each recipient (Spearman’s p-value; 0.141 and 0.519 respectively).
When the patients were divided to groups of large LAV (n = 17) and small LAV (n = 18) using the cut off value of
the mean LAV, no significant difference was noted in mortality, hospitalization, and new onset of atrial fibrillation
between the groups.
Conclusions: Although our study is limited by a retrospective study design and relatively small number of patients,
our results implicate that LAV is not significantly associated with clinical outcomes in HT recipients over 5 years
after HT.
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Background
Left atrial volume (LAV) is enlarged in heart transplant
(HT) recipients [1, 2]. Enlarged LAV seems negatively cor-
related with exercise capacity [1] and it may be detrimental
to clinical outcomes in HT recipients since limited exercise
capacity has known to be a poor prognostic factor in vari-
ous cardiovascular diseases such as heart failure and atrial
fibrillation [3–5]. In addition, it is unknown whether LAV
can still correlate with clinical outcomes in the setting of
artificially enlarged LAV because previous published studies
examining a predictive value of LAV in clinical outcomes
only have been described in altered LAV naturally by dis-
ease processes [6–8]. Therefore, a clinical relevance of
artificially dilated LAV to clinical outcomes is largely
unknown.
In this study, we tested whether artificially enlarged
LAV by HT is still associated with clinical outcomes in
this population to address the above concerns.
Methods
Study population
This clinical protocol was approved by the Institutional
Review Board and was consistent with the principles of
the Declaration of Helsinki [9]. Due to the retrospective
nature of the study, waiver of consent was approved.
Patients with heart failure who underwent post HT
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clinical follow up were included when the following con-
ditions were met: 1) Post HT follow up was performed
in our institution, 2) Baseline post-HT echocardiography
was performed at 12 months of post HT, 3) No more
than mild mitral regurgitation during baseline echocar-
diography, 4) No clinically significant myocardial ische-
mia with stress testing at the time of study entry, 5)
Normal sinus rhythm, 6) No clinically significant active
transplant rejection at the time of study entry. LAV was
measured at 12 months from HT to avoid the effect of
acute hemodynamic changes due to the HT surgical pro-
cedure. Thirty-five patients who visited our clinic for a
post HT follow up between 2000 and 2007 met the in-
clusion criteria. All cases received standard left atrial
cuff anastomosis.
Echocardiographic measurements
The patients were imaged with multi-frequency trans-
ducers with center frequencies of 2.5 or 3.5 MHz (iE33,
Philips Medical System, Bothell WA, Vivid 7 GE Health-
care system, Milwaukee, WI). Studies were recorded
digitally and stored in the Camtronics Imaging system
(Emageon Camtronics system, Birmingham AL). LAV
measurements were performed off-line on digital loops
using a Digisonics review station (version 3.2 software,
Digisonics Inc. Houston, TX) as previously reported by
our group [1, 7, 10, 11]. LAV were measured using ap-
ical 4 and 2 chamber views at end systole using a
stacked disc method. Briefly, in all cases pulmonary
veins and the LA appendage were excluded from plani-
metric analysis. The outline of the atrial endocardium
was traced at the end of ventricular systole at the point
of maximum left atrial dimension. We used this method
over the area-length method recommended by the
American Society of Echocardiography [12] to calculate
LAV because our method is based by fewer geometric
assumption than the area-length method. The studies
were blinded and measured by a single reader (Y.S.).
Clinical outcomes
Over 5-year period from HT, the medical chart of each
patient was retrospectively reviewed. Frequency of death,
cardiac symptom-related hospitalization, and atrial fibril-
lation were recorded for the analyses. The cardiac
symptom-related hospitalization was defined as a
hospitalization due to shortness of breath, chest pain,
dizziness, palpitations, and peripheral edema which was
accompanied with an admitting physician’s note indicat-
ing a suspected cardiac cause. The time to first admis-
sion was measured as previously described [13, 14].
Statistical analysis
Data are presented mean ± S.D. for measurements. The
relationship between LAV and clinical outcome variables
were analyzed by a Spearman correlation test. Event free
and survival analyses between the groups were made by
a Kaplan-Meyer analysis. Clinical outcomes between the
groups were compared with a χ-square test. All tests




The average age of study population at the time of HT
was 52 ± 16 years. Ten were female (29 %). Among the
patients investigated, most were asymptomatic. Twenty-
eight patients (80 %) were NYHA class I and no patient
showed clinically significant rejection (International So-
ciety for Heart and Lung Transplantation grade II or
more). Baseline echocardiography showed that the aver-
age LAV was 77.3 ± 21.6 ml and LAV normalized to
body surface area (BSA) was 38.3 ± 9.9 ml/m2. Both
values were higher than our historical normal values
[11], reflecting typical HT morphology. One mildly to
moderately reduced and two mildly reduced left ven-
tricular systolic function were reported in this cohort.
One mild and two moderate left ventricular diastolic
dysfunction were reported in this cohort; however, left
ventricular diastolic function was not reportable in 6 pa-
tients. Seventeen patients (49 %) demonstrated indexed
LAV more than the average value of this group.
Clinical outcomes
A total of 552 cardiac symptom-related hospitalizations
occurred in this group. No hospitalization was noted in
4 patients. The average time to first hospitalization was
166 ± 279 days and average number of hospitalizations
of each recipient was 15 ± 16. Two deaths and 2 post
HT atrial fibrillation were noted over 5-year retrospect-
ive clinical follow up in this group.
Relationship between LAV and clinical outcomes
The indexed LAV failed to correlate with the time to
first hospitalization and number of hospitalizations of
each recipient (Spearman’s p-value; 0.141 and 0.519 re-
spectively; Fig. 1). The absolute LAV also did not correl-
ate with them significantly (Spearman’s p-value; 0.438
and 0.560 respectively). To assess a clinical significance
of LAV in clinical outcomes, the cohort was divided to
patients with LAV > the average value (38.3 ml/m2, LL
group, n = 17) and patients with LAV ≤ the average value
(SL group, n = 18). Two deaths, 256 hospitalization, and
1 post transplant atrial fibrillation occurred in LL group.
No death, 266 hospitalization, and 1 post transplant
atrial fibrillation occurred in SL group. These incidences
were statistically not different between the groups. Both
mortality reflected by overall survivaland time to first
cardiac symptom-related hospitalization reflected by
Ahmad et al. Journal of Cardiothoracic Surgery  (2015) 10:96 Page 2 of 5
hospitalization free survivaldid not defer statistically be-
tween LL and SL groups with a Kaplan-Meier analysis
(log-rank test; 0.151 and 0.393 respectively; Fig. 2).
Discussion
The results of the present study demonstrate that in this
cohort of HT patients, the size of left atrium measured
with LAV is not associated with clinical outcomes mea-
sured with mortality, hospitalization, and atrial fibrilla-
tion over 5-year period after HT.
Although larger LAV is associated with lesser exercise
capacity in our previous publication [1], LAV fails to asso-
ciate clinical outcomes in this study. LAV has been previ-
ously reported to correlate with clinical outcomes in
variety of cardiac pathologies including coronary artery
disease [15, 16] and heart failure [8, 17]. But this
relationship has not been tested in the setting of
surgically-altered, artificially-dilated left atrium and our
results show that this relationship is not established al-
though our patient population is small and may not iden-
tify weak associations. It is widely believed that dilation of
LAV is a reflection of chronic degree of left ventricular
diastolic function [18] and in turn chronicity of left ven-
tricular diastolic dysfunction correlates with clinical out-
comes. Transplant hearts have been reported to have
normal left ventricular diastolic function irrespective of
enlarged LA [1, 19] in the absence of clinically significant
allograft rejection and this dissociation of left atrial size
from left ventricular diastolic function at baseline may be
a culprit of its failure to associate with clinical outcomes.
A decrease in exercise capacity has been known for a
poor prognostic marker in heart failure [3, 5] and coronary
Fig. 1 The relationships of left atrial volume normalized to body surface area with time to first cardiac-symptom related hospitalization (panel a,
n = 31) and number of hospitalizations (panel b, n = 35) are shown. Spearman’s correlation p values are shown
Fig. 2 The Kaplan-Myer plots of mortality reflected by overall survival(panel a) and time to first cardiac-symptom related hospitalization reflected
by hospitalization free survival(panel b) are shown. The unbroken lines denote patients with indexed left atrial volume to body surface area
smaller than or equal to its average of this study population (n = 18). The dotted lines denote patients with indexed left atrial volume to body sur-
face area larger than the average of this study population (n = 17). Please refer to the text for details. p values from a log-rank test are shown
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artery disease [20]. Our results suggest that this relationship
may not be applicable to HT population within 5 years
from HT although LAV is associated with exercise capacity
in this population like in the other cardiac diseases [1].
However, our results do not preclude the possibility that
exercise capacity still affects the clinical outcomes in HT
population because the other surrogate markers of exercise
capacity rather than LAV were not evaluated on this study
and further investigation is warranted to address this. We
speculate that in HT population, conventional clinical out-
come predictors may not be usable and that unknown or
lesser known clinical outcome predictors may exist. For in-
stance, factors unique to HT such as response to immuno-
suppressive therapy may be more influential to clinical
outcomes than traditional predictors such as LAV and exer-
cise capacity and further investigation is warranted to
identify these.
However, a caution should apply to our observation.
The retrospective nature of this study and relatively small
sample size are the primary limitations of the present in-
vestigation. The 5-year observation period may also not be
sufficient to conclude an accurate assessment of predictive
value of LAV in clinical outcomes in our HT recipients.
Although not statistically significant, a small number of
deaths were only noted in the patients with large LAV
group, not those with small LAV. This difference between
the groups may reach a statistical significance if this ana-
lysis is repeated after longer duration of observation time
than this study. To further strengthen our findings, a pro-
spective study addressing these issues in a larger HT co-
hort over longer time period is required.
Conclusion
In conclusion, our study shows that LAV is not signifi-
cantly associated with clinical outcomes in HT recipients
over 5-year follow up from HT. Further investigation to
verify this observation is therefore warranted.
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